Is a hematocrit of 47.2% normal for an adult and what follow‑up is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hematocrit 47.2% Assessment

A hematocrit of 47.2% falls within the normal physiological range for adult males and postmenopausal females (47 ± 6%), but is mildly elevated for premenopausal women (normal 41 ± 5%); no immediate intervention is required, but the value should be interpreted in the context of sex, altitude, and clinical symptoms. 1, 2

Normal Reference Ranges by Sex and Age

For adult males and postmenopausal females:

  • Normal hematocrit: 47 ± 6% (range approximately 41–53%) 2
  • Normal hemoglobin: 15.5 ± 2.0 g/dL 2

For premenopausal (menstruating) females:

  • Normal hematocrit: 41 ± 5% (range approximately 36–46%) 2
  • Normal hemoglobin: 14.0 ± 2.0 g/dL 2

Your value of 47.2% is:

  • Normal for males/postmenopausal females 2
  • Mildly elevated (approximately 95th percentile) for premenopausal women 1

Altitude Adjustment Required

If you live at altitude ≥3,000 feet (914 meters), your hematocrit should be interpreted with upward adjustment: 3

  • At 1,500 meters: add +0.5 g/dL to hemoglobin (approximately +1.5% to hematocrit) 1, 3
  • At 2,000 meters: add +0.8 g/dL to hemoglobin (approximately +2.4% to hematocrit) 1, 3
  • At 4,000 meters: normal male hematocrit averages 52.7% (range 45–61%) 4

Failure to adjust for altitude leads to overdiagnosis of polycythemia and underdiagnosis of anemia. 3

When to Investigate Further

Repeat measurement is warranted if: 1

  • You are a premenopausal woman (47.2% exceeds typical female range) 1, 2
  • You have symptoms of hyperviscosity (headache, blurred vision, confusion, bleeding) 1
  • You have documented progressive rise over 6 months 1
  • You have thrombocytosis, leukocytosis, or splenomegaly 1

Initial laboratory workup should include: 1

  • Complete blood count with red cell indices (MCV, MCH, MCHC, RDW) 1
  • Serum ferritin and transferrin saturation (iron deficiency can coexist with erythrocytosis) 1
  • Reticulocyte count 1
  • White blood cell differential and platelet count 1

Diagnostic Thresholds for True Erythrocytosis

True erythrocytosis requiring JAK2 mutation testing is defined as: 1

  • Hemoglobin >18.5 g/dL in men OR >16.5 g/dL in women 1
  • AND hematocrit >52% in men OR >48% in women 1

Your value of 47.2% does NOT meet these thresholds for mandatory polycythemia vera workup. 1

When Phlebotomy Is Indicated

Therapeutic phlebotomy is indicated ONLY when ALL of the following are present: 1

  • Hemoglobin >20 g/dL AND hematocrit >65% 1
  • Documented hyperviscosity symptoms 1
  • Adequate hydration confirmed 1
  • Iron deficiency excluded 1

Your value of 47.2% is far below the 65% threshold; phlebotomy is NOT indicated and would be harmful. 1

Clinical Significance of Borderline-High Hematocrit

Even hematocrit values in the high-normal range (45–49%) are associated with increased cardiovascular risk: 5

  • In the Framingham Heart Study, hematocrit >45% (compared to <40%) was associated with a 78% increased risk of developing heart failure over 20 years (HR 1.78,95% CI 1.15–2.75) 5
  • This association persisted after adjusting for cardiovascular risk factors and remained significant in nonsmokers 5

However, in chronic kidney disease, hematocrit 33–36% is associated with 10% reduced mortality compared to 30–33%, suggesting context-dependent optimal ranges. 2, 6

Recommended Follow-Up

For asymptomatic individuals with hematocrit 47.2%: 1

  • If male or postmenopausal female at sea level: No immediate action required; routine monitoring 2
  • If premenopausal female: Repeat measurement to confirm; if persistent, obtain complete blood count with indices and iron studies 1
  • If living at altitude ≥3,000 feet: Apply altitude adjustment before determining if value is abnormal 3
  • Serial measurements every 6–12 months are appropriate for borderline values to detect progression 1

Common Pitfalls to Avoid

Do not perform phlebotomy for hematocrit <65% without documented hyperviscosity symptoms and adequate hydration. 1

Do not overlook coexisting iron deficiency—serum ferritin and transferrin saturation must be checked, as iron deficiency mimics hyperviscosity but requires iron supplementation, not phlebotomy. 1

Do not use sea-level reference ranges for patients living at altitude ≥3,000 feet—this leads to misdiagnosis. 3

Hemoglobin is more reliable than hematocrit for monitoring because hematocrit can falsely increase 2–4% with prolonged sample storage, while hemoglobin remains stable. 1, 2

References

Guideline

Assessment Protocol for Incidental Erythrocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hematocrit and Hemoglobin Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hemoglobin and Hematocrit Values at High Altitudes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hematocrit level and associated mortality in hemodialysis patients.

Journal of the American Society of Nephrology : JASN, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.